Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
skip to main content

Protect NIH. Protect Patients.

NIHWhat’s Happening
Since January 2025, more than $1.5 billion in NIH funding has been frozen. At the same time, proposed legislation (H.R. 1497) would dismantle the National Institute of Allergy and Infectious Diseases (NIAID) — the cornerstone of federal support for allergy and immunology — splitting it into three separate institutes. If these changes move forward, the consequences for our specialty and our patients will be profound.

What’s at Risk
NIH funding supports:
•    Research on asthma, food allergies, eczema and immune deficiencies
•    Clinical trials at academic centers
•    Training the next generation of A/I specialists
•    Access to innovative treatments nationwide

Breaking up NIAID would sever vital connections between allergy, immunology and infectious disease research — halting critical progress and collaboration.

Why It Matters
This isn’t just about science — it’s about patient care and public health. Unified allergy, immunology and infectious disease research is essential for pandemic response, vaccine development, and protecting against future health threats. Weakening NIAID undermines this preparedness.

Impact on A/I
NIH funding has enabled:
•    Biologic therapies for asthma
•    Breakthroughs in food allergy immunotherapy and prevention
•    Improved eczema treatments
•    Better care for immune deficiencies

Without it, clinical trials will stall, breakthroughs will slow and fewer allergists will be trained — especially in rural and underserved areas.

What AAAAI Is Doing
To fight these threats, AAAAI has launched the Scientific Community Task Force for A/I Research. This task force is actively advocating in Congress to oppose H.R. 1497, demand the release of frozen NIH funds, and protect essential research infrastructure.

The crucial impact of NIH funding on allergy/immunology patient care and research
Barrett NA, Nowak-Wegrzyn A, Bacharier LB, Bansal P, Kabbash LG, Orange JS, Williams PV, Virant FS, Davis CM, Brandt R, Fleisher TA, on behalf of the AAAAI Scientific Community Task Force for Allergy/Immunology Research. Journal of Allergy and Clinical Immunology: Global (2025)

Read about how the AAAAI is advocating for the NIH and NIAID to help safeguard the allergy / immunology specialty. Carla M. Davis, MD, FAAAAI, AAAAI President-Elect and Chair of the AAAAI Scientific Community Task Force for A/I Research, explains what’s at stake and why this issue is so critical for the specialty.

How You Can Help
We’ve taken the first step — now we need your voice. Join us in defending the future of our specialty and the patients we serve.
•    Contact your elected representatives. It takes just minutes using the prepared template.
•    Amplify the message!
     o    Use these talking points to show we are many speaking with one voice.
     o    Personalize the social media templates and post on your social media platforms, or like and share the AAAAI social media posts.
•    Raise awareness. Personalize the op-ed template and submit it to your local or regional paper.
•    Stay informed. Listen to our podcast discussion of the issues and share it with your networks.

On World Asthma Day (May 6, 2025) we celebrated by taking action. AAAAI members met with lawmakers on Capitol Hill along with The Asthma and Allergy Foundation of America (AAFA) to call on Congress to restore and protect critical programs. View the handouts and find out more about the visit. 

6/4/2025

OSZAR »